Evidence map›Paper›PMID 39229520›Full record

ArticleHeliyon2024

CircRAPGEF5 acts as a modulator of RAS/RAF/MEK/ERK signaling during colorectal carcinogenesis.

Zhipeng Yin, Hao Li, Heng Zhao, Lutterodt Bentum-Ennin, Yang Xia, Zaibiao Wang, Wanglai Hu, Hao Gu, Shangxin Zhang, Guangyun Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhipeng YinDepartment of Gastrointestinal Surgery, The People's Hospital of Bozhou, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou, China.
Hao LiDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Heng ZhaoDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Lutterodt Bentum-EnninDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Yang XiaDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Zaibiao WangDepartment of Gastrointestinal Surgery, The People's Hospital of Bozhou, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou, China.
Wanglai HuDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Hao GuDepartment of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Shangxin ZhangDepartment of Gastrointestinal Surgery, Department of General Surgery, First Affiliated Hospital of Anhui Medical University, Hefei, China.
Guangyun LiDepartment of Gastrointestinal Surgery, The People's Hospital of Bozhou, The Affiliated Bozhou Hospital of Anhui Medical University, Bozhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in oncogenes such as

Indexed as

ApoptosisCircRAPGEF5Colorectal cancerRAS/RAF/MEK/ERK signaling

Identifiers

PMID39229520
PMCPMC11369509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.